DBL Pharmaceuticals Limited Starts Journey

9 November 2021

DBL Group started its journey in the pharmaceutical industry. The BDT 700-crore factory located at Kashimpur, Gazipur following the guidelines of US FDA, WHO, GMP has been inaugurated on 7 November 2021 by the Honorable Minister, Zahid Maleque MP, Ministry of Health and Family Welfare, Govt. of the People’s Republic of Bangladesh.

Maj. Gen. Md. Mahbubur Rahman, Director General, DGDA; Dr. Habib-E-Millat MP; Prof. Dr. S. M. Abdur Rahman, Dean, Faculty of Pharmacy, University of Dhaka were present in this auspicious occasion as special guests. From DBL Group- Abdul Wahed, Chairman; M. A. Jabbar, Managing Director; M. A. Rahim, Vice Chairman; M. A. Quader, Deputy Managing Director & Group CEO were present among other high officials.

Honorable Health Minister in the Chief Guest’s speech mentioned about the success of govt. in fighting COVID-19 through successful vaccination programs. He also emphasized, “the number of affected cases considering Bangladesh population is low if we compare with many other countries specially our neighboring country India. Definitely it is a sign of improvement of our health sector.” Along with that he expressed his expectations of seeing high quality products from DBL Pharmaceuticals Limited as DBL has already set its standard in a high position at all their previous factories, investments, and projects.

Before the Chief Guest’s Speech, Managing Director of DBL, M. A. Jabbar said in his Welcome Speech

“Sustainable Development and Sound Technology are in the keynotes of DBL Group. The Pharma factory of DBL will have the same reflection. We have already stepped in the Unites States of America through contract manufacturing by one of our sister concerns DBL Pharmaceuticals Inc. They are marketing 2 generic medicines in USA with success. In near future, we have plans and are hopeful that we will directly export products manufactured in this plant (Gazipur, Kashimpur) to USA along with other developed countries.”